Sort
78,016 grants matching “breast cancer”
PENN RCMAR
$623,665Jerry Calvin Johnson · University Of Pennsylvania · P30 · FY2009 · AG
Epidemiology of Molecular Risk Factors for Breast Cancer
$623,660William D Dupont · Vanderbilt University · R01 · FY2007 · CA
Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors
$623,601Siobhan Marie Phillips · Northwestern University At Chicago · R37 · FY2025 · CA
Alliance for Clinical Trials in Oncology Operations Center - GY11 BIQSFP Funded Extension
$623,526Steven Piantadosi · Brigham And Women'S Hospital · U10 · FY2025 · CA
NEXT-GENERATION MOLECULAR HISTOLOGY USING HIGHLY MULTIPLEXED ION-BEAM IMAGING (MIBI) OF BREAST CANCER TISSUE SPECIMENS FOR ENHANCED CLINICAL GUIDANCE
$623,524University Of California, Davis · · FY2014 · Department of the Army
(PQC2)High-content Pathology with Confocal Microscope Arrays
$623,480Christopher H Contag · Stanford University · R01 · FY2014 · CA
Protein and proteolytic activity biomarkers of early stage pancreatic cancer
$623,472Paul Tempst · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Protein and proteolytic activity biomarkers of early stage pancreatic cancer
$623,472Paul Tempst · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Acceptance and Commitment Therapy for Fear of Recurrence in Breast Cancer Survivors
$623,355Shelley A. Johns · Indiana University Indianapolis · R01 · FY2023 · CA
Impact of Affect Reactivity and Regulation on Breast Cancer Treatment Decisions
$623,354David Spiegel · Stanford University · U01 · FY2016 · CA
Research Program
$623,251Alison Meredith Buttenheim · University Of Pennsylvania · P50 · FY2023 · CA
A nested case-control study of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and breast cancer risk in the Multiethnic Cohort
$623,229Eunjung Lee · University Of Southern California · R01 · FY2024 · CA
Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment
$623,178Elizabeth Marjorie Cespedes Feliciano · Kaiser Foundation Research Institute · R01 · FY2024 · CA
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
$623,145Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Digital Pathology_Accuracy Viewing Behavior and Image Characterization
$623,127Joann G Elmore · University Of Washington · R01 · FY2014 · CA
Functional Determinants of Metastatic Dormancy
$623,104Julio A Aguirre-Ghiso · Albert Einstein College Of Medicine · R01 · FY2023 · CA
Functional Determinants of Metastatic Dormancy
$623,104Julio A Aguirre-Ghiso · Albert Einstein College Of Medicine · R01 · FY2025 · CA
Biomarkers and Breast Cancer Risk Prediction in Younger Women
$623,103Anne Zeleniuch-Jacquotte · New York University School Of Medicine · R01 · FY2014 · CA
Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation with Movement to Improve Prognosis in Breast Cancer Survivors
$623,101Christina Dieli-Conwright · Dana-Farber Cancer Inst · R01 · FY2022 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP--WISCONSIN STUDIES
$623,064University Of Wisconsin Madison · U10 · FY2003 · CA
Atlanta Regional Community Clinical Oncology Program
$623,000Thomas E Seay · St. Joseph'S Hospital · U10 · FY2007 · CA
Optimizing Individualized and Adaptive mHealth Interventions via Control Systems Engineering Methods
$622,967Eric Hekler · University Of California, San Diego · R01 · FY2023 · CA
OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY
$622,961Gregory M Lanza · Washington University · R01 · FY2021 · CA
OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY
$622,961Gregory M Lanza · Washington University · R01 · FY2018 · CA
OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY
$622,961Gregory M Lanza · Washington University · R01 · FY2020 · CA